Literature DB >> 27335701

High prevalence of hypovitaminosis D of patients with autoimmune rheumatic diseases in China.

Zhao-Hui Zheng1, Cong-Cong Gao1, Zhen-Zhen Wu1, Sheng-Yun Liu1, Tian-Fang Li1, Guan-Min Gao1, Zhang-Suo Liu1.   

Abstract

We aimed to determine the prevalence of hypovitaminosis D in patients with autoimmune rheumatic diseases (ARDs) in China and its association with demographic characteristics of the patients. We recruited 384 patients in this cross-sectional study including 121 cases of systemic lupus erythematosus (SLE), 131 rheumatoid arthritis (RA), 102 spondyloarthritis (SpA) and 30 other ARDs. For each patient, demographic information was collected and serum concentration of 25OHD3 was measured by electrochemiluminescence immunoassay (ECLIA). The multivariate logistic regression model was used to investigate the association between vitamin D deficiency and patient characteristics. The mean serum vitamin D level of the 384 patients was 18.91 (8.12) ng/mL, and the median age was 37.33 (12.01) yrs. Among these patients, 222 (57.81%) and 127 (33.07%) were found to be vitamin D deficiency and insufficiency, respectively. From the disease perspective, the percentages of insufficiency and deficiency were as follow: 97.52% and 84.30% in SLE, 87.02% and 48.85% in RA, 88.24% and 40.20% in SpA, 90.89% and 57.81% in other ARDs patients. The causative factors for vitamin D deficiency included SLE per se (OR 12.54, P < 0.001) and high body mass index (BMI) (OR 1.88, P < 0.001). However, the seniors were less likely to have vitamin D deficiency (OR 0.95, P = 0.005). No correlation was disclosed between vitamin D deficiency and gender or disease duration. Hypovitaminosis D is highly prevalent among autoimmune rheumatic diseases population in China. The SLE per se and the obesity are the risk factors for vitamin D deficiency. Clinicians are advised to supplement vitamin D in these patients.

Entities:  

Keywords:  25OHD3; Autoimmune rheumatic diseases; hypovitaminosis D; prevalence; vitamin D

Year:  2016        PMID: 27335701      PMCID: PMC4913223     

Source DB:  PubMed          Journal:  Am J Clin Exp Immunol


  32 in total

Review 1.  Vitamin D deficiency.

Authors:  Michael F Holick
Journal:  N Engl J Med       Date:  2007-07-19       Impact factor: 91.245

Review 2.  Resurgence of vitamin D: Old wine in new bottle.

Authors:  Raju Vaishya; Vipul Vijay; Amit Kumar Agarwal; Jabed Jahangir
Journal:  J Clin Orthop Trauma       Date:  2015-03-26

3.  Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus.

Authors:  M C Hochberg
Journal:  Arthritis Rheum       Date:  1997-09

4.  Prevalence of Vitamin D inadequacy among postmenopausal North American women receiving osteoporosis therapy.

Authors:  Michael F Holick; Ethel S Siris; Neil Binkley; Mary K Beard; Aliya Khan; Jennifer T Katzer; Richard A Petruschke; Erluo Chen; Anne E de Papp
Journal:  J Clin Endocrinol Metab       Date:  2005-03-29       Impact factor: 5.958

Review 5.  Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes.

Authors:  Heike A Bischoff-Ferrari; Edward Giovannucci; Walter C Willett; Thomas Dietrich; Bess Dawson-Hughes
Journal:  Am J Clin Nutr       Date:  2006-07       Impact factor: 7.045

6.  Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria.

Authors:  S van der Linden; H A Valkenburg; A Cats
Journal:  Arthritis Rheum       Date:  1984-04

Review 7.  Vitamin D levels in Chinese patients with systemic lupus erythematosus: relationship with disease activity, vascular risk factors and atherosclerosis.

Authors:  Chi Chiu Mok; Daniel J Birmingham; Hoi Wah Leung; Lee A Hebert; Huijuan Song; Brad H Rovin
Journal:  Rheumatology (Oxford)       Date:  2011-06-29       Impact factor: 7.580

Review 8.  Clinical aspects of vitamin D in the management of rheumatoid arthritis.

Authors:  P Leventis; S Patel
Journal:  Rheumatology (Oxford)       Date:  2008-08-05       Impact factor: 7.580

9.  Vitamin D3 metabolism in patients with rheumatic diseases: low serum levels of 25-hydroxyvitamin D3 in patients with systemic lupus erythematosus.

Authors:  K Müller; N J Kriegbaum; B Baslund; O H Sørensen; M Thymann; K Bentzen
Journal:  Clin Rheumatol       Date:  1995-07       Impact factor: 2.980

10.  Influence of season and latitude on the cutaneous synthesis of vitamin D3: exposure to winter sunlight in Boston and Edmonton will not promote vitamin D3 synthesis in human skin.

Authors:  A R Webb; L Kline; M F Holick
Journal:  J Clin Endocrinol Metab       Date:  1988-08       Impact factor: 5.958

View more
  5 in total

1.  Prevalence of depression and anxiety in rheumatoid arthritis patients and their associations with serum vitamin D level.

Authors:  Dan Pu; Jing Luo; Yanhua Wang; Bomiao Ju; Xiaohong Lv; Ping Fan; Lan He
Journal:  Clin Rheumatol       Date:  2017-10-23       Impact factor: 2.980

2.  Association of High Calcitriol Serum Levels and Its Hydroxylation Efficiency Ratio with Disease Risk in SLE Patients with Vitamin D Deficiency.

Authors:  Mónica R Meza-Meza; José Francisco Muñoz-Valle; Adolfo I Ruiz-Ballesteros; Barbara Vizmanos-Lamotte; Isela Parra-Rojas; Erika Martínez-López; Edith Oregon-Romero; Yolanda Fabiola Márquez-Sandoval; Sergio Cerpa-Cruz; Ulises de la Cruz-Mosso
Journal:  J Immunol Res       Date:  2021-12-31       Impact factor: 4.818

3.  High Prevalence of Hypovitaminosis D in Cutaneous and Systemic Lupus Erythematosus Patients and Its Associated Factors: A Cross-Sectional Study in Thailand.

Authors:  Silada Kanokrungsee; Chanikarn Patcharapojanart; Poonkiat Suchonwanit; Kumutnart Chanprapaph
Journal:  Clin Cosmet Investig Dermatol       Date:  2022-08-17

Review 4.  Vitamin D in Systemic Sclerosis: A Review.

Authors:  Mattia Perazzi; Enrico Gallina; Giulia Francesca Manfredi; Filippo Patrucco; Antonio Acquaviva; Donato Colangelo; Mario Pirisi; Mattia Bellan
Journal:  Nutrients       Date:  2022-09-21       Impact factor: 6.706

Review 5.  Vitamin D Deficiency and Rheumatoid Arthritis: Epidemiological, Immunological, Clinical and Therapeutic Aspects.

Authors:  Behzad Heidari; Karimollah Hajian-Tilaki; Mansour Babaei
Journal:  Mediterr J Rheumatol       Date:  2019-06-29
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.